Literature DB >> 7615289

Ecstasy induced hepatitis mimicking viral hepatitis.

R S Dykhuizen1, P W Brunt, P Atkinson, J G Simpson, C C Smith.   

Abstract

Three cases of jaundice after ingestion of 3,4-methylenedioxymetamphetamine (MDMA), known as 'ecstasy', are reported and the complications associated with the misuse of this drug, which was initially misrepresented as 'safer than alcohol' are described. Ingestion of 'ecstasy' should be considered when investigating unexplained jaundice in younger patients.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7615289      PMCID： PMC1382638          DOI： 10.1136/gut.36.6.939

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  9 in total

1.  Ecstasy-fueled 'rave' parties become dances of death for English youths.

Authors:  T Randall
Journal:  JAMA       Date:  1992 Sep 23-30       Impact factor: 56.272

2.  Ecstasy and the dance of death.

Authors:  J A Henry
Journal:  BMJ       Date:  1992-07-04

3.  'Rave' scene, ecstasy use, leap atlantic.

Authors:  T Randall
Journal:  JAMA       Date:  1992 Sep 23-30       Impact factor: 56.272

4.  Misuse of ecstasy.

Authors:  J D Shearman; R W Chapman; J Satsangi; N G Ryley; S Weatherhead
Journal:  BMJ       Date:  1992-08-01

5.  Misuse of ecstasy.

Authors:  D A Gorard; S E Davies; M L Clark
Journal:  BMJ       Date:  1992-08-01

6.  Knowledge and experience of young people regarding drug abuse, 1969-89.

Authors:  J D Wright; L Pearl
Journal:  BMJ       Date:  1990-01-13

7.  Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')

Authors:  C Brown; J Osterloh
Journal:  JAMA       Date:  1987-08-14       Impact factor: 56.272

8.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Authors:  J A Henry; K J Jeffreys; S Dawling
Journal:  Lancet       Date:  1992-08-15       Impact factor: 79.321

9.  'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA.

Authors:  G P Dowling; E T McDonough; R O Bost
Journal:  JAMA       Date:  1987-03-27       Impact factor: 56.272
  9 in total
  10 in total

Review 1.  Ten years of 'ecstasy'.

Authors:  C M Milroy
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

Review 2.  Recent advances: hepatology.

Authors:  M McCarthy; M L Wilkinson
Journal:  BMJ       Date:  1999-05-08

3.  Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case series.

Authors:  Jennifer J E Nicol; Mark C Yarema; Graham R Jones; Walter Martz; Roy A Purssell; Judy C MacDonald; Ian Wishart; Monica Durigon; Despina Tzemis; Jane A Buxton
Journal:  CMAJ Open       Date:  2015-01-13

Review 4.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 5.  Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Authors:  U D McCann; S O Slate; G A Ricaurte
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

6.  "Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series.

Authors:  C M Milroy
Journal:  Forensic Sci Med Pathol       Date:  2011-01-25       Impact factor: 2.007

7.  Acute liver damage and ecstasy ingestion.

Authors:  A J Ellis; J A Wendon; B Portmann; R Williams
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

8.  High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics.

Authors:  A R Mackenzie; R B Laing; J G Douglas; M Greaves; C C Smith
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

Review 9.  Nephrotoxic effects of designer drugs: synthetic is not better!

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2014-03-25       Impact factor: 28.314

Review 10.  3,4-methylenedioxymethamphetamine (MDMA): a review.

Authors:  G O'Leary; J Nargiso; R D Weiss
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 8.081
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.